Effectiveness of a vancomycin restriction policy in changing the prescribing patterns of house staff

被引:21
作者
Richardson, LP [1 ]
Wiseman, SW [1 ]
Malani, PN [1 ]
Lyons, MJ [1 ]
Kauffman, CA [1 ]
机构
[1] Univ Michigan, Sch Med, Ann Arbor Vet Affairs Healthcare Syst, Div Infect Dis & Pharm Serv, Ann Arbor, MI 48105 USA
关键词
D O I
10.1089/mdr.2000.6.327
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
After noting a rise in vancomycin-resistant enterococci (VRE) infections, we initiated a program to decrease inappropriate vancomycin use that focused on improvement of house staff prescribing practices. The initial intervention in June, 1995, encouraging house staff to follow hospital guidelines for vancomycin use and eliciting support from service chiefs in this effort, had little impact. A more intensive educational intervention, beginning in January, 1996, involved concurrent review of all vancomycin orders and one-on-one discussion with the house staff regarding the rationale for the order by an infectious diseases clinical pharmacist. When usage was deemed inappropriate, the pharmacist;asked that vancomycin be discontinued, but no automatic stop orders were issued. During the next two and one-half years, this second intervention proved effective at decreasing inappropriate use from 39% to 16.8% +/- 2.4% (p = 0.005). This change was primarily due to a decrease in appropriate vancomycin prophylaxis by cardiothoracic surgery, VRE infections decreased from 0.29/100 patients discharged prior to initiating the program to 0.13/100 patients discharged after the second intervention (p = 0.01). This educational program, although labor-intensive, preserved house staff decision-making skills related to antibiotic prescribing at the same time that it decreased inappropriate vancomycin use.
引用
收藏
页码:327 / 330
页数:4
相关论文
共 20 条
[1]  
Adachi W, 1997, Hospital Pharmacy, V32, P1370
[2]   Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium [J].
Anglim, AM ;
Klym, B ;
Byers, KE ;
Scheld, WM ;
Farr, BM .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (10) :1132-1136
[3]  
[Anonymous], 1995, INFECT CONT HOSP EP, V16, P105
[4]   Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit [J].
Archibald, L ;
Phillips, L ;
Monnet, D ;
McGowan, JE ;
Tenover, F ;
Gaynes, R .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :211-215
[5]   Limiting vancomycin use to combat vancomycin-resistant Enterococcus faecium [J].
Belliveau, PP ;
Rothman, AL ;
Maday, CE .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (13) :1570-1575
[6]  
Bonilla HF, 1997, INFECT CONT HOSP EP, V18, P333, DOI 10.1086/647621
[7]  
BURKE CE, 1997, AM J HEALTH-SYST PH, V54, P1983
[8]  
*CDCP, 1993, NOS ENT RES VANC US, P597
[9]   THE EPIDEMIOLOGY OF INTRAVENOUS VANCOMYCIN USAGE IN A UNIVERSITY HOSPITAL - A 10-YEAR STUDY [J].
ENA, J ;
DICK, RW ;
JONES, RN ;
WENZEL, RP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (05) :598-602
[10]   Vancomycin use in a university medical center: Effect of a vancomycin continuation form [J].
Evans, ME ;
Millheim, ET ;
Rapp, RP .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (06) :417-420